Friday, December 13, 2024

Cyclodialysis Data Show Lower IOP, Medication Burden

Twelve-month results from the ongoing CREST Registry study highlight the safety and efficacy of a bio-interventional approach.

Wednesday, December 11, 2024

Bausch + Lomb Affiliate Acquires Elios Vision

The company is seeking FDA approval for its MIGS procedure using an excimer laser, which has been approved in Europe.  

Tuesday, December 10, 2024

ViaLase, Moran Eye Center Announce Research Partnership

Researchers will study aqueous outflow dynamics using the company’s innovative laser procedure to lower intraocular pressure.

Friday, December 6, 2024

Meta-analysis Finds Laser Therapy Comparable to Glaucoma Drugs

A review of past studies finds that selective laser trabeculoplasty offers comparable pressure control to medications, with fewer complications.

Friday, December 6, 2024

Glaucoma Risk Assessment Measure Is Less Accurate for Patients of African Ancestry

Study suggests tailored models could improve predictive accuracy and outcomes for underserved populations.

Friday, December 6, 2024

Repeat SLT Found Effective for Most Glaucoma Patients

Chinese study supports repeat SLT as a treatment option despite initial response variability.

Friday, December 6, 2024

Study Evaluates Paul Glaucoma Implant Effectiveness

Clinical outcomes at 2 years include significant IOP reduction and decreased need for medication.

Wednesday, November 20, 2024

SpyGlass Completes Tigris Trial Enrollment

The phase 1/2 trial will compare the IOP-reducing effect of SpyGlass Pharma's bimatoprost-eluting IOL to treatment with timolol ophthalmic solution in glaucoma patients undergoing cataract surgery.

Friday, November 15, 2024

Trial Data Finds Drug-eluting Contact Lens Safe, Effective

Results of MediPrint Ophthalmics’s phase 2b trial for LL-BMT1, presented at AAOpt, indicated that the lenses could be a safe and effective alternative to daily glaucoma drops.

Tuesday, November 12, 2024

Konan Launches objectiveFIELD Device

Now available in the United States, the objectiveFIELD bilateral visual field analyzer measures pupillary responses to spatially resolved stimuli.

Monday, October 28, 2024

FDA Appoints Dr. Michelle Tarver as CDRH Director

The new director of the FDA’s Center for Devices and Radiological Health brings 15 years of FDA experience and a background in ophthalmology.

Friday, October 25, 2024

SpyGlass Pharma Releases Data on Drug-eluting IOL

The company presented 18-month data at Eyecelerator that showed sustained IOP reduction after cataract surgery.

Wednesday, October 23, 2024

Microdose Eye Spray Limits Cytotoxicity

Researchers found the Optejet technology reduces the harmful effect of preservatives in multiuse latanoprost eye drops.

Wednesday, October 23, 2024

Study Highlights Waste of Eye Drops

Research presented at AAO shows clinics discard most eye drops long before expiration.

Friday, October 11, 2024

iCare Introduces the ST500 Slit Lamp Tonometer

The new slit lamp tonometer offers a combination of iCare rebound technology and slit-lamp based tonometry

Thursday, September 26, 2024

Zeiss Introduces Ultrasound-free Lens Extraction Device

The company says the Micor 700’s non-ultrasound approach minimizes thermal stress and tissue damage during cataract surgery.

Wednesday, September 25, 2024

Lumibird Launches AI-assisted Imaging Device

The Omnicad platform combines high-definition imaging and artificial intelligence for easier diagnosis of ocular surface disease.

Tuesday, September 24, 2024

Chronic Stress Linked to Glaucoma Risk, NIH Study Finds

Research also highlights a potential link between allostatic load, which is a stress measurement, and racial disparities in glaucoma prevalence.

Monday, September 23, 2024

MST to Distribute Vista Products Globally

The deal includes Vista 1-Step and Vista IS products, which are intended to enhance vitrectomy procedures.

Monday, September 23, 2024

Nicox Announces Glaukos Option Agreement

The agreement aims to explore the therapeutic potential of Nicox’s nitric oxide-donating PDE5 inhibitor, NCX 1728, in glaucoma treatment.

Monday, September 23, 2024

Ripple, AbbVie to Partner on Glaucoma Treatment

The collaboration focuses on developing RTC-620, a biodegradable implant that is designed to reduce intraocular pressure.

Thursday, September 12, 2024

Uveoscleral Glaucoma Treatment Shows Promising Results

Study demonstrates the effectiveness of Iantrek’s biointerventional technology in treating open-angle glaucoma.

Sunday, September 8, 2024

Proximal Disc Hemorrhages Signal Glaucoma Risk

Cup-type hemorrhages linked to faster disease progression.

Sunday, September 8, 2024

Glaucoma in Myopic Eyes Studied

A long-term study supports the impact of IOP reduction on the progression of glaucoma in highly myopic patients.

Sunday, September 8, 2024

CMS Seeks Feedback on Medicare Contractor Consolidation

Agency considers merging jurisdictions and extending contracts to improve efficiency.

Sunday, September 8, 2024

Ciliatech Presents 3-Year Data on Novel Device

New study shows sustained IOP reduction and decreased medication dependence in patients implanted with a cilioscleral interpositioning device.

Thursday, August 29, 2024

First IOP Sensor Implanted in Eye

The IOP-Connect device, currently under development, will provide real-time IOP monitoring from inside the eye.

Tuesday, August 20, 2024

Early Outcomes Show Promise for Inferotemporal Stent Implantation

Novel surgical approach demonstrates significant IOP and medication reductions.

Tuesday, August 20, 2024

Visiox Pharmaceuticals, Ocuvex Therapeutics to Merge

Company officials say the merger will strengthens their ophthalmic portfolio and accelerate  commercialization of products.

Tuesday, August 20, 2024

Study Compares Microshunt to Trabeculectomy

Preserflo device shows efficacy and safety comparable to traditional filtering surgery in a 2-year study.

Tuesday, August 20, 2024

Long-term Study Shows GDD Success

Ahmed ClearPath glaucoma drainage device demonstrates safety and effectiveness over 3 years.

Tuesday, August 20, 2024

Novel Microstent Shows Promise

A study using rabbit models finds the Wistend microstent safe and effective in reducing IOP.

Monday, August 12, 2024

New Visual Field Test Shows Promise

Online circular contrast perimetry demonstrates good repeatability and reliability in glaucoma screening and monitoring, study finds.

Tuesday, August 6, 2024

FDA Adverse Event Database Reveals Lesser-known Drugs Linked to Glaucoma

A Rutgers study analyzes 20 years of FDA records, finding some lesser-known drugs linked to reports of POAG.